<DOC>
	<DOCNO>NCT00543465</DOCNO>
	<brief_summary>This study look incidence gastric and/or duodenal ulcer patient osteoarthritis rheumatoid arthritis four different treatment group ( ) MK0782 21 mg plus enteric-coated aspirin , ( b ) MK0782 42 mg plus enteric-coated aspirin , ( c ) celecoxib 200 mg plus enteric-coated aspirin , enteric-coated aspire alone . This early phase trial specific protocol information progress publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>12-Week No-Rofecoxib Plus Aspirin Endoscopy Study ( 0782-003 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Has osteoarthritis rheumatoid arthritis least 6 month prior start study Osteoarthritis ( OA ) : must diagnosis OA knee , hip , hand spine Patient chronic aspirin therapy ( take aspirin dose , daily basis , minimum 4 week prior Visit 2 medical condition Must willing limit alcohol use 2 drink per day Avoid strenuous physical activity Mentally legally incapacitate Has systemic lupus erythematosus , Paget 's disease Has history esophageal , gastric biliary , small intestine surgery ( hiatal surgery GI surgery cause clinical malabsorption delay gastric emptying Has uncontrolled hypertension Has uncontrolled diabetes Has heart attack , unstable angina , coronary angioplasty , stent placement , coronary artery bypass graft last 6 month Has congestive heart failure Has active liver disease within last 2 year</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>